Literature DB >> 30799155

Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Laura Bergantini1, Elena Bargagli2, Paolo Cameli2, Behar Cekorja2, Nicola Lanzarone2, Lucrezia Pianigiani2, Lucia Vietri2, David Bennett2, Piersante Sestini2, Paola Rottoli2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30799155     DOI： 10.1016/j.resinv.2019.02.001

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  13 in total

1.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

2.  Serum KL-6 concentrations as a novel biomarker of severe COVID-19.

Authors:  Miriana d'Alessandro; Paolo Cameli; Rosa Metella Refini; Laura Bergantini; Valerio Alonzi; Nicola Lanzarone; David Bennett; Giuseppe Domenico Rana; Francesca Montagnani; Sabino Scolletta; Federico Franchi; Bruno Frediani; Serafina Valente; Maria Antonietta Mazzei; Francesco Bonella; Elena Bargagli
Journal:  J Med Virol       Date:  2020-06-09       Impact factor: 2.327

Review 3.  Mucins as a New Frontier in Pulmonary Fibrosis.

Authors:  Beatriz Ballester; Javier Milara; Julio Cortijo
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241

4.  Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.

Authors:  Ding-Hui Peng; Yi Luo; Li-Jun Huang; Fan-Lu Liao; Yan-Yuan Liu; Peng Tang; Han-Ning Hu; Wei Chen
Journal:  Clin Chim Acta       Date:  2021-02-22       Impact factor: 3.786

5.  Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy.

Authors:  Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Maria Pieroni; Rosa Metella Refini; Piersante Sestini; Elena Bargagli
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

Review 6.  Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.

Authors:  Anna Stainer; Paola Faverio; Sara Busnelli; Martina Catalano; Matteo Della Zoppa; Almerico Marruchella; Alberto Pesci; Fabrizio Luppi
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

7.  Mucins and their receptors in chronic lung disease.

Authors:  Emma Denneny; Jagdeep Sahota; Richard Beatson; David Thornton; Joy Burchell; Joanna Porter
Journal:  Clin Transl Immunology       Date:  2020-03-17

8.  Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases.

Authors:  Laura Bergantini; Miriana d'Alessandro; Lucia Vietri; Giuseppe Domenico Rana; Paolo Cameli; Silvia Acerra; Piersante Sestini; Elena Bargagli
Journal:  Immunol Res       Date:  2020-10-22       Impact factor: 2.829

9.  Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.

Authors:  Yuya Aono; Yutaro Nakamura; Masato Kono; Hidenori Nakamura; Koshi Yokomura; Shiro Imokawa; Mikio Toyoshima; Hideki Yasui; Hironao Hozumi; Masato Karayama; Yuzo Suzuki; Kazuki Furuhashi; Noriyuki Enomoto; Tomoyuki Fujisawa; Naoki Inui; Takafumi Suda
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 10.  Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings.

Authors:  Giulia Elena Mandoli; Carlotta Sciaccaluga; Francesco Bandera; Paolo Cameli; Roberta Esposito; Antonello D'Andrea; Vincenzo Evola; Regina Sorrentino; Alessandro Malagoli; Nicolò Sisti; Dan Nistor; Ciro Santoro; Elena Bargagli; Sergio Mondillo; Maurizio Galderisi; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.